Nutrition
Volume 21, Issue 9 , Pages 889-894, September 2005

Use of oral nutritional supplements in patients with Huntington’s disease

  • Araceli Trejo, B.S.

      Affiliations

    • Nutrition Laboratory, Instituto Nacional de Neurología y Neurocirugía “MVS”, Mexico D.F., Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +011-5255-5606-4120, ext. 2052; fax: +011-5255-5424-0808.
  • ,
  • Marie-Catherine Boll, M.D., M.Sc.

      Affiliations

    • Department of Neurology, Instituto Nacional de Neurología y Neurocirugía “MVS”, Mexico D.F., Mexico
  • ,
  • Ma. Elisa Alonso, M.D.

      Affiliations

    • Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía “MVS”, Mexico D.F., Mexico
  • ,
  • Adriana Ochoa, B.S.

      Affiliations

    • Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía “MVS”, Mexico D.F., Mexico
  • ,
  • Leora Velásquez, M.D., M.Sc.

      Affiliations

    • Department of Neuroepidemiology, Instituto Nacional de Neurología y Neurocirugía “MVS”, Mexico D.F., Mexico

Received 11 May 2004; accepted 1 December 2004. published online 08 August 2005.

Abstract 

Objective

This study assessed the effect of oral nutritional supplements on the nutritional status of patients with Huntington’s disease.

Methods

This was an experimental, longitudinal, prospective study of 30 patients with Huntington’s disease. We performed neurologic evaluation and dietary assessment and measured anthropometric indexes and biochemical indicators; in addition, patients were questioned about their weight, appetite, chewing difficulty, and dysphagia. Patients consumed two cans daily of a nutritional supplement that contributed an extra 473 kcal to their diet for a 90-d period. At the study’s end, the supplement was suspended and the same variables were reassessed.

Results

After 90 d, 68.7% of patients had increased body weight, 68.7% had ideal body weight percentages and body mass indexes, 53.3% had increased midarm circumferences, and 60.0% had increased arm muscle circumferences and body fat percentages; these changes were statistically significant (P < 0.05). The neurologic evaluation subscales and the biochemical indicators did not change significantly. With regard to subjective variables, patients who reported losing weight during the 3 mo before the study did not lose more weight and patients who reported having an increased appetite before the study remained stable during the study.

Conclusions

The nutritional intervention stabilized or slightly improved the anthropometric variables assessed; however, no significant change in body mass index occurred in 87% of patients. For the purpose of maintaining an acceptable nutritional status in patients who have Huntington’s disease and normal nutritional status, we suggest oral nutritional supplements that contribute an average of 473 kcal/d in addition to a normal diet.

Keywords:  Oral nutritional supplements , Huntington’s disease , Nutritional status , Undernourishment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by Fresenius Kabi, Mexico.

PII: S0899-9007(05)00158-9

doi:10.1016/j.nut.2004.12.012

Nutrition
Volume 21, Issue 9 , Pages 889-894, September 2005